Doreen V. Morgan

Doreen V. Morgan has a wealth of work experience in the regulatory affairs field. Doreen V. currently serves as Vice President, Head of Global Regulatory Strategy at PTC Therapeutics, Inc. Prior to this, they were the VP Global Regulatory at Mesoblast Limited before joining PTC Therapeutics. Doreen also held positions at LEO Pharma, serving as Vice President US Regulatory Affairs & QA from 2017 to 2019 and Vice President of US Regulatory Affairs from 2015 to 2017. Doreen V. worked as an Executive Director of Regulatory Affairs at Daiichi Sankyo from 2007 to 2015. Before that, they were the Sr. Director of Regulatory Affairs at Forest Research Institute from 2001 to 2007. Earlier in their career, Doreen held positions at Knoll Pharmaceuticals, Hoffman La Roche, and Schering-Plough Pharmaceuticals, focusing on regulatory affairs and drug safety management.

Doreen V. Morgan holds a Pharm.D. degree in pharmacy from St. John's University.